Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009.

Slides:

Advertisements

Similar presentations

The role of lercanidipine in the treatment of hypertension:

Advertisements

Secretory Phospholipase A2: A New Risk Factor and Soon a New Target of Therapy Rabih R. Azar, MD, MSc, FACC Associate Professor of Medicine Division of.

% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England.

Drugs in dyslipidaemias

MIRACL, Val-HeFT, Cheney Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director of the Joseph J Jacobs Center.

GP VTS Teaching 24 th February, 2009 PRESCRIBING IN THE ELDERLY Dr Rob Dent.

Congestive heart failure

Drug calculation formula

CARDIVASCULAR DRUGS Sanjukta (2009). CARDIOVASCULAR DISEASE AND DRUGS ► Basic cardiovascular physiology and pathology depends on the control of heart.

Trends in Usage of Non-Opioid Analgesics in General Practice in England © Copyright NHSBSA 2008.

Pharmacological Treatment of Hypertension Update 2012.

Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.

Indication:  Suspected Heart Failure With abnormal ECG or Intermediate BNP ( ) BNP:  Asymptomatic Murmur  Asymptomatic Cardiomegaly On CXR Direct.

Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.

Trends in Spending on Selective Beta 2 Agonists in General Practice in England.

Trends in Prescribing of Selected Alpha-Blockers in General Practice in England © Copyright NHSBSA 2008.

Trends in Prescribing of Sodium Chloride Irrigation Solutions in General Practice in England © Copyright NHSBSA 2008.

To understand about drug interaction in every day practice, and to refresh our memory to most common and important interactions.

What’s the point of Ezetimibe? MeReC dio/cdlipids/merec_extra_no47.html.

Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.

Chapter 12 Urinary System Drugs Copyright © 2011 Delmar, Cengage Learning.

AFAMS Cardiovascular Drugs (Insert Dari) EO Part 19.

Pharmacology of Heart failure

National Therapeutic Indicators – How can EMIS help? Dr Keith Burns, EMIS NUG Committee, Broadbay Medical Practice, Stornoway.

% Ratio of Prescribing of Antidepressant, Hypnotic and Antipsychotic Drugs in General Practice in England © Copyright NHSBSA 2009.

Step 3 P-treatment: Drug Class Selection. Pharmacological and Non- Pharmacological Management Dyslipidemia drug therapyLifestyle modification Smoking.

SATURN: Objective To compare the effects of rosuvastatin 40 mg versus atorvastatin 80 mg on progression of coronary atherosclerosis assessed by intravascular.

Slide Source Hypertension Online Copyright Notice You are authorized to use these slides subject to the following terms, conditions.

Pie Chart Showing the Breakdown of Gastro-intestinal Prescribing in General Practice in England (July June 2008 ) © Copyright NHSBSA 2008.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 46 Vasodilators.

Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.

David J. Graham et al. JAMA, 2004; 292: 2585 Description of Inception Cohorts for Patients Using Statin and Fibrate Drug Therapy.

Drugs Affecting the Cardiovascular System. Cardiovascular System Z Muscular organ with 4 chambers Z Pumps 5-6 liters blood/minute.

Slide Source: Lipids Online Slide Library ASTEROID Population at Baseline (n=507) Patients Completing (n=349) Patients Not Completing.

Cardiac Rehabilitation Program Understanding Cardiac Medications

Trends in Spending on Selective Beta 2 Agonists in General Practice in England © Copyright NHSBSA 2009.

Online additional material Appendix Table 1: Medications Groups Appendix Table 2: Doctors' orders in hemodialysis units Additional Figure 1: Beta Blockers.

Polypill x Aspirin Project Groups 3 and 4

CRESTOR ® (ZD4522, rosuvastatin calcium) TABLETS Comments on Efficacy Joy Mele FDA Statistical Reviewer Division of Biometrics 2 Joy Mele FDA Statistical.

Diuretics and Antihypertensives

HLD Tx & AHA/ACC Guidelines

Cardiovascular Calcium Chanel Blockers Ace Inhibitors Anticoagulant/ Diuretics Lipid Lowering.

DRUG INTERACTIONS I Lecture #36. Drug Interactions Terms Therapeutic Drug Interaction ADR Additive Synergism.

Why they do what they do (2014). Students will be able to:  Review the pathological process of Hypertension, Coronary Artery Disease and Heart Failure.

Effect of some adrenergic drugs and its blockers on the blood pressure.

Decreasing the Load After the Fill May the Force be with you Clearing the Path Let it Flow

Diuretics Diuretics (natriuretics) are drugs which cause a net loss of Na+ and water in urine.

Date of download: 5/28/2016 From: New Fibrate Use and Acute Renal Outcomes in Elderly Adults: A Population-Based Study Ann Intern Med. 2012;156(8):

Generic Lipitor 10mg Order Atorvastatin Online atorvastatin crystalline form magkano lipitor if my lipitor is from mylan is it ok lipitor 20 mg reacciones.

Prescribing in cardiovascular disease By Jole Hannan Medicines Optimisation Pharmacist.

Cardiac Medications Hypertension. Learning Objectives  Students will be able to:  Discuss the major categories of drugs as they relate to the treatment.

MEDICINES & THE HEART. Medicines & the Heart You and your medicines You and your medicines Common heart medicines for preventing heart disease Common.

Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.

Can Buy Atorvastatin Atorvastatin Cheap lipitor side effects libido effects of lipitor with alcohol lipitor creator rosuvastatin 5 mg vs atorvastatin 10.

أبدا لم يفت الاوان لكي تبدأ

By: Dr Israa Omar MBBS, MRCP, MSc pharmacology

The Anglo Scandinavian Cardiac Outcomes Trial

Pharmacology of the CVS

Volume 19, Issue 6, Pages (September 2016)

Cardiovascular Disease Risk Reduction Advances in Dyslipidemia

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

Perreault S, et al. Eur J Clin Pharmacol 2009 Jun 16 [Epub]

Opening a New Lipid “Apo-thecary”: Incorporating Apolipoproteins as Potential Risk Factors and Treatment Targets to Reduce Cardiovascular Risk Terry.

Updates on Dyslipidemia

Heart Disease HIV/AIDS Tuberculosis Malaria.

Copyright Notice You are authorized to use these slides subject to the following terms, conditions and exceptions: They are to be used solely for personal,

Presentation transcript:

Trends in Prescribing of and Spending on Digoxin in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Thiazides and Related Diuretics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Thiazides and Related Diuretics in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Bendroflumethiazide Tabs/Caps in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Spironolactone Caps/Tabs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Potassium-sparing Diuretics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Potassium-sparing Diuretics in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Potassium-sparing Diuretics with Other Diuretics in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Potassium-sparing Diuretics with Other Diuretics in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Amiodarone in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Beta-adrenoceptor Blocking Drugs (including Combinations) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Beta-adrenoceptor Blocking Drugs (including Combinations) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Alpha-adrenoceptor Blocking Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Alpha-adrenoceptor Blocking Drugs in General Practice in England © Copyright NHSBSA 2009

% Ratio of Prescribing of ACE Inhibitors vs Angiotensin-II Receptor Antagonists © Copyright NHSBSA 2009

% Ratio of Spending on ACE Inhibitors vs Angiotensin-II Receptor Antagonists © Copyright NHSBSA 2009

Trends in Prescribing of ACE Inhibitors (including combinations) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on ACE Inhibitors (including combinations) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Angiotensin-II Receptor Antagonists (including combinations) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Angiotensin-II Receptor Antagonists (including combinations) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Nitrates in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Nitrates in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Calcium-channel Blockers in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Calcium-channel Blockers in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Nicorandil in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Peripheral Vasodilators in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Peripheral Vasodilators in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Warfarin in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Antiplatelet Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Antiplatelet Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Aspirin BNF 2.9 (E/C Tablets vs Other Formulations) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Aspirin BNF 2.9 (E/C Tablets vs Other Formulations) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Lipid-regulating Drugs (excluding Statins) in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Lipid-regulating Drugs (excluding Statins) in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Ezetimibe in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Fibrates in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Fibrates in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Nicotinic Acid Group Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Nicotinic Acid Group Drugs in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Statins in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Statins in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Atorvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Atorvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Simvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Simvastatin Tabs by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of Rosuvastatin by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Spending on Rosuvastatin by Strength in General Practice in England © Copyright NHSBSA 2009

Trends in Prescribing of and Spending on Inegy® in General Practice in England © Copyright NHSBSA 2009

% Ratio of Prescribing of High Strength Statins (Atorvastatin 40mg / 80mg, Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy®) vs All Other Statins in General Practice in England © Copyright NHSBSA 2009

% Ratio of Spending on High Strength Statins (Atorvastatin 40mg / 80mg, Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy®) vs All Other Statins in General Practice in England © Copyright NHSBSA 2009